Sponsor or institution

Clinical trials and research at International Vaccine Institute

• 7Clinical trials
• 10Countries

Newest trials

All recruiting trials (7)

• Age-descending safety and immune response of a cholera conjugate vaccine in people aged 1–45

  This trial will test whether one or two doses of a 25 μg cholera conjugate vaccine, with or without an aluminum adjuvant, are safe and produce immune responses in people aged 1 to 45 living in a cholera-endemic area.

  Recruiting Phase 2 International Vaccine Institute · Nairobi, Kenyatta National Hospital Complex · NCT07509047

• Do malaria vaccines lower the risk of invasive non-typhoidal Salmonella in young children?

  This study will see if the R21/Matrix-M malaria vaccine lowers the chance of invasive non-typhoidal Salmonella disease in children under 5 who come to health facilities with fever in the Kisantu Health Zone (DRC).

  Recruiting International Vaccine Institute · Kinshasa · NCT07416461

• HPV Immunization in Ghana to See if Vaccine Works in Babies and Teens

  This study tests whether a bivalent HPV vaccine is safe and can provoke an immune response in healthy infants and young children, and compares it to responses seen in unmarried young women aged 15–20 in Ghana.

  Recruiting Phase 2 International Vaccine Institute · Accra · NCT07377656

• Compare Biovac OCV-S and Euvichol‑Plus for immunogenicity, safety, and lot consistency

  This research will test whether the oral vaccine Biovac OCV‑S works as well and is as safe as Euvichol‑Plus for children, healthy adults, and adults living with HIV.

  Recruiting at 2 sites Phase 3 International Vaccine Institute · Durban, Eastern Cape and 4 other locations · NCT07304284

• See if LC16m8 mpox vaccine protects people in the DRC

  This study tests whether the LC16m8 mpox vaccine helps prevent mpox in people aged 12 months and older in the DRC.

  Recruiting International Vaccine Institute · Kinshasa · NCT07093489

• Evaluating the safety and immune response of Hecolin® vaccine in children and adults

  This study is testing the Hecolin® vaccine for Hepatitis E in healthy children and adults to see how safe it is and how well it works to boost their immune response.

  Recruiting at 3 sites Phase 2 International Vaccine Institute · Ga-Rankuwa and 2 other locations · NCT06306196

• Estimating the prevalence of high-risk HPV infections in women and girls across multiple countries

  This study is trying to find out how common high-risk HPV infections are in girls and women aged 9-50 in different countries, especially in low-income areas.

  Recruiting International Vaccine Institute · Dhaka and 7 other locations · NCT06129253

Quick answers

How many clinical trials run by International Vaccine Institute are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in Democratic Republic of the Congo (3 trials), South Africa (2 trials), Ghana (2 trials), Kenya (1 trial), Bangladesh (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →